Omeros
About OmerosPipelineInvestorsNews
PharmacoSurgeryMASPInflammationCNS DisordersBleeding DisordersGPCRsantibody

Inflammation

 

PharmacoSurgery®

Our proprietary PharmacoSurgery® products are designed to improve the clinical outcomes of patients undergoing ophthalmologicalarthroscopicurological and other surgical and medical procedures. OMIDRIA® (phenylephrine and ketorolac injection) 1%/0.3%, is the first approved drug from our PharmacoSurgery platform.

MASP